Logo image of HMSB.DE

HENNES & MAURITZ AB-B SHS (HMSB.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:HMSB - SE0000106270 - Common Stock

16.94 EUR
+0.12 (+0.71%)
Last: 12/22/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, HMSB scores 4 out of 10 in our fundamental rating. HMSB was compared to 59 industry peers in the Specialty Retail industry. While HMSB belongs to the best of the industry regarding profitability, there are concerns on its financial health. HMSB is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

HMSB had positive earnings in the past year.
In the past year HMSB had a positive cash flow from operations.
In the past 5 years HMSB has always been profitable.
HMSB had a positive operating cash flow in each of the past 5 years.
HMSB.DE Yearly Net Income VS EBIT VS OCF VS FCFHMSB.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1.2 Ratios

With a decent Return On Assets value of 6.33%, HMSB is doing good in the industry, outperforming 72.88% of the companies in the same industry.
With an excellent Return On Equity value of 27.78%, HMSB belongs to the best of the industry, outperforming 84.75% of the companies in the same industry.
The Return On Invested Capital of HMSB (12.24%) is better than 79.66% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HMSB is below the industry average of 10.63%.
The 3 year average ROIC (7.98%) for HMSB is below the current ROIC(12.24%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.33%
ROE 27.78%
ROIC 12.24%
ROA(3y)4.41%
ROA(5y)4.01%
ROE(3y)16.88%
ROE(5y)14.25%
ROIC(3y)7.98%
ROIC(5y)6.98%
HMSB.DE Yearly ROA, ROE, ROICHMSB.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

HMSB has a better Profit Margin (4.71%) than 71.19% of its industry peers.
In the last couple of years the Profit Margin of HMSB has declined.
HMSB has a better Operating Margin (7.49%) than 69.49% of its industry peers.
In the last couple of years the Operating Margin of HMSB has remained more or less at the same level.
Looking at the Gross Margin, with a value of 53.07%, HMSB is in the better half of the industry, outperforming 79.66% of the companies in the same industry.
HMSB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.49%
PM (TTM) 4.71%
GM 53.07%
OM growth 3Y-0.56%
OM growth 5Y0.23%
PM growth 3Y-3.61%
PM growth 5Y-3.01%
GM growth 3Y0.42%
GM growth 5Y0.31%
HMSB.DE Yearly Profit, Operating, Gross MarginsHMSB.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

3

2. Health

2.1 Basic Checks

HMSB has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, HMSB has less shares outstanding
The number of shares outstanding for HMSB has been reduced compared to 5 years ago.
Compared to 1 year ago, HMSB has an improved debt to assets ratio.
HMSB.DE Yearly Shares OutstandingHMSB.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
HMSB.DE Yearly Total Debt VS Total AssetsHMSB.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

The Debt to FCF ratio of HMSB is 4.12, which is a neutral value as it means it would take HMSB, 4.12 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 4.12, HMSB perfoms like the industry average, outperforming 59.32% of the companies in the same industry.
A Debt/Equity ratio of 1.49 is on the high side and indicates that HMSB has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.49, HMSB is doing worse than 74.58% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF 4.12
Altman-Z N/A
ROIC/WACC3.34
WACC3.66%
HMSB.DE Yearly LT Debt VS Equity VS FCFHMSB.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

HMSB has a Current Ratio of 1.05. This is a normal value and indicates that HMSB is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of HMSB (1.05) is worse than 69.49% of its industry peers.
HMSB has a Quick Ratio of 1.05. This is a bad value and indicates that HMSB is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.51, HMSB is in line with its industry, outperforming 44.07% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.51
HMSB.DE Yearly Current Assets VS Current LiabilitesHMSB.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.13% over the past year.
Measured over the past years, HMSB shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.32% on average per year.
HMSB shows a decrease in Revenue. In the last year, the revenue decreased by -1.57%.
HMSB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.15% yearly.
EPS 1Y (TTM)8.13%
EPS 3Y2.83%
EPS 5Y-2.32%
EPS Q2Q%39.58%
Revenue 1Y (TTM)-1.57%
Revenue growth 3Y5.63%
Revenue growth 5Y0.15%
Sales Q2Q%-3.38%

3.2 Future

The Earnings Per Share is expected to grow by 10.19% on average over the next years. This is quite good.
Based on estimates for the next years, HMSB will show a small growth in Revenue. The Revenue will grow by 1.67% on average per year.
EPS Next Y0.03%
EPS Next 2Y7.84%
EPS Next 3Y8.08%
EPS Next 5Y10.19%
Revenue Next Year-2.97%
Revenue Next 2Y-0.84%
Revenue Next 3Y0.26%
Revenue Next 5Y1.67%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HMSB.DE Yearly Revenue VS EstimatesHMSB.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B 200B 250B
HMSB.DE Yearly EPS VS EstimatesHMSB.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 27.32, which means the current valuation is very expensive for HMSB.
HMSB's Price/Earnings ratio is in line with the industry average.
HMSB is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.61, which is the current average of the S&P500 Index.
HMSB is valuated rather expensively with a Price/Forward Earnings ratio of 22.00.
HMSB's Price/Forward Earnings ratio is in line with the industry average.
HMSB's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.01.
Industry RankSector Rank
PE 27.32
Fwd PE 22
HMSB.DE Price Earnings VS Forward Price EarningsHMSB.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

HMSB's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HMSB is cheaper than 62.71% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, HMSB is valued a bit cheaper than the industry average as 61.02% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.43
EV/EBITDA 7.98
HMSB.DE Per share dataHMSB.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HMSB does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of HMSB may justify a higher PE ratio.
PEG (NY)816.51
PEG (5Y)N/A
EPS Next 2Y7.84%
EPS Next 3Y8.08%

4

5. Dividend

5.1 Amount

HMSB has a Yearly Dividend Yield of 3.62%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.41, HMSB pays a better dividend. On top of this HMSB pays more dividend than 86.44% of the companies listed in the same industry.
HMSB's Dividend Yield is rather good when compared to the S&P500 average which is at 1.87.
Industry RankSector Rank
Dividend Yield 3.62%

5.2 History

The dividend of HMSB decreases each year by -7.85%.
Dividend Growth(5Y)-7.85%
Div Incr Years1
Div Non Decr Years4
HMSB.DE Yearly Dividends per shareHMSB.DE Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2021 2022 2023 2024 2025 2 4 6 8

5.3 Sustainability

HMSB pays out 98.12% of its income as dividend. This is not a sustainable payout ratio.
DP98.12%
EPS Next 2Y7.84%
EPS Next 3Y8.08%
HMSB.DE Yearly Income VS Free CF VS DividendHMSB.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B
HMSB.DE Dividend Payout.HMSB.DE Dividend Payout, showing the Payout Ratio.HMSB.DE Dividend Payout.PayoutRetained Earnings

HENNES & MAURITZ AB-B SHS

FRA:HMSB (12/22/2025, 7:00:00 PM)

16.94

+0.12 (+0.71%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)09-25 2025-09-25/bmo
Earnings (Next)01-29 2026-01-29/amc
Inst Owners21.49%
Inst Owner ChangeN/A
Ins Owners1.2%
Ins Owner ChangeN/A
Market Cap23.89B
Revenue(TTM)231.26B
Net Income(TTM)10.88B
Analysts49.71
Price Target14.67 (-13.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.62%
Yearly Dividend0.59
Dividend Growth(5Y)-7.85%
DP98.12%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.78%
Min EPS beat(2)-3.66%
Max EPS beat(2)29.22%
EPS beat(4)2
Avg EPS beat(4)-3.8%
Min EPS beat(4)-46.79%
Max EPS beat(4)29.22%
EPS beat(8)3
Avg EPS beat(8)-6.65%
EPS beat(12)6
Avg EPS beat(12)-1.38%
EPS beat(16)8
Avg EPS beat(16)-8.67%
Revenue beat(2)0
Avg Revenue beat(2)-2.06%
Min Revenue beat(2)-2.48%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-2.74%
Min Revenue beat(4)-3.95%
Max Revenue beat(4)-1.64%
Revenue beat(8)0
Avg Revenue beat(8)-2.5%
Revenue beat(12)0
Avg Revenue beat(12)-2.32%
Revenue beat(16)0
Avg Revenue beat(16)-2.23%
PT rev (1m)3.39%
PT rev (3m)13.18%
EPS NQ rev (1m)-0.56%
EPS NQ rev (3m)-0.46%
EPS NY rev (1m)-0.44%
EPS NY rev (3m)3.41%
Revenue NQ rev (1m)-0.58%
Revenue NQ rev (3m)-0.97%
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)-0.42%
Valuation
Industry RankSector Rank
PE 27.32
Fwd PE 22
P/S 1.13
P/FCF 14.43
P/OCF 8.77
P/B 6.65
P/tB 8.35
EV/EBITDA 7.98
EPS(TTM)0.62
EY3.66%
EPS(NY)0.77
Fwd EY4.55%
FCF(TTM)1.17
FCFY6.93%
OCF(TTM)1.93
OCFY11.4%
SpS15.04
BVpS2.55
TBVpS2.03
PEG (NY)816.51
PEG (5Y)N/A
Graham Number5.96
Profitability
Industry RankSector Rank
ROA 6.33%
ROE 27.78%
ROCE 17.23%
ROIC 12.24%
ROICexc 15.35%
ROICexgc 17.04%
OM 7.49%
PM (TTM) 4.71%
GM 53.07%
FCFM 7.81%
ROA(3y)4.41%
ROA(5y)4.01%
ROE(3y)16.88%
ROE(5y)14.25%
ROIC(3y)7.98%
ROIC(5y)6.98%
ROICexc(3y)9.84%
ROICexc(5y)8.7%
ROICexgc(3y)10.94%
ROICexgc(5y)9.68%
ROCE(3y)11.28%
ROCE(5y)9.86%
ROICexgc growth 3Y2.73%
ROICexgc growth 5Y-9.12%
ROICexc growth 3Y3.25%
ROICexc growth 5Y-7.29%
OM growth 3Y-0.56%
OM growth 5Y0.23%
PM growth 3Y-3.61%
PM growth 5Y-3.01%
GM growth 3Y0.42%
GM growth 5Y0.31%
F-Score7
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF 4.12
Debt/EBITDA 1.49
Cap/Depr 53.28%
Cap/Sales 5.03%
Interest Coverage 7.89
Cash Conversion 75.81%
Profit Quality 165.92%
Current Ratio 1.05
Quick Ratio 0.51
Altman-Z N/A
F-Score7
WACC3.66%
ROIC/WACC3.34
Cap/Depr(3y)39.04%
Cap/Depr(5y)30.46%
Cap/Sales(3y)3.79%
Cap/Sales(5y)3.17%
Profit Quality(3y)328.53%
Profit Quality(5y)606.52%
High Growth Momentum
Growth
EPS 1Y (TTM)8.13%
EPS 3Y2.83%
EPS 5Y-2.32%
EPS Q2Q%39.58%
EPS Next Y0.03%
EPS Next 2Y7.84%
EPS Next 3Y8.08%
EPS Next 5Y10.19%
Revenue 1Y (TTM)-1.57%
Revenue growth 3Y5.63%
Revenue growth 5Y0.15%
Sales Q2Q%-3.38%
Revenue Next Year-2.97%
Revenue Next 2Y-0.84%
Revenue Next 3Y0.26%
Revenue Next 5Y1.67%
EBIT growth 1Y1.03%
EBIT growth 3Y5.03%
EBIT growth 5Y0.38%
EBIT Next Year126.7%
EBIT Next 3Y35.48%
EBIT Next 5Y19.92%
FCF growth 1Y-22.46%
FCF growth 3Y-20.98%
FCF growth 5Y1.72%
OCF growth 1Y-5.05%
OCF growth 3Y-10.72%
OCF growth 5Y1.84%

HENNES & MAURITZ AB-B SHS / HMSB.DE FAQ

What is the ChartMill fundamental rating of HENNES & MAURITZ AB-B SHS (HMSB.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to HMSB.DE.


Can you provide the valuation status for HENNES & MAURITZ AB-B SHS?

ChartMill assigns a valuation rating of 3 / 10 to HENNES & MAURITZ AB-B SHS (HMSB.DE). This can be considered as Overvalued.


Can you provide the profitability details for HENNES & MAURITZ AB-B SHS?

HENNES & MAURITZ AB-B SHS (HMSB.DE) has a profitability rating of 7 / 10.


What are the PE and PB ratios of HENNES & MAURITZ AB-B SHS (HMSB.DE) stock?

The Price/Earnings (PE) ratio for HENNES & MAURITZ AB-B SHS (HMSB.DE) is 27.32 and the Price/Book (PB) ratio is 6.65.


What is the earnings growth outlook for HENNES & MAURITZ AB-B SHS?

The Earnings per Share (EPS) of HENNES & MAURITZ AB-B SHS (HMSB.DE) is expected to grow by 0.03% in the next year.